IHM-Spike

N/A

Report date: 2025/01/26 17:46:27

Base Information

Drug NameIHM-Spike
Drug Alias NameCOVID19 spike glycoprotein modulator (MaxiVAX)SARS-CoV-2 vaccine (MaxiVAX)
ClassificationBiologics
Mechanisms of ActionCoronavirus spike glycoprotein modulators
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMaxivax Sa
China Registration ClassN/A

Develop Information

Active CompaniesMaxivax SaUniversity Of Geneva
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A